Rachel Hammond

2.7k total citations
41 papers, 2.1k citations indexed

About

Rachel Hammond is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rachel Hammond has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Immunology. Recurrent topics in Rachel Hammond's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Transplantation: Methods and Outcomes (4 papers). Rachel Hammond is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Transplantation: Methods and Outcomes (4 papers). Rachel Hammond collaborates with scholars based in United States, United Kingdom and Italy. Rachel Hammond's co-authors include Asa Abeliovich, Phyllis A. Gimotty, David MacLeod, Keiichi Inoue, Thomas Leete, George Coukos, Shetal Patel, Brian Keith, M. Celeste Simon and Lijun Yuan and has published in prestigious journals such as Journal of Clinical Investigation, Neuron and Journal of Clinical Oncology.

In The Last Decade

Rachel Hammond

39 papers receiving 2.1k citations

Peers

Rachel Hammond
Joshua D. Bernstock United States
Hans Maier Austria
Eun Joo Chung South Korea
David E. Szymkowski United States
Rachel Hammond
Citations per year, relative to Rachel Hammond Rachel Hammond (= 1×) peers Manuel Deprez

Countries citing papers authored by Rachel Hammond

Since Specialization
Citations

This map shows the geographic impact of Rachel Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Hammond more than expected).

Fields of papers citing papers by Rachel Hammond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Hammond. The network helps show where Rachel Hammond may publish in the future.

Co-authorship network of co-authors of Rachel Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Hammond. A scholar is included among the top collaborators of Rachel Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Hammond. Rachel Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammond, Rachel, et al.. (2022). Incorporating hearing screening to an otolaryngology surgical mission in the rural Dominican Republic. International Journal of Pediatric Otorhinolaryngology. 160. 111222–111222. 1 indexed citations
2.
Roseweir, Antonia K., Tahir Qayyum, Rachel Hammond, et al.. (2016). Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients. BMC Cancer. 16(1). 229–229. 31 indexed citations
3.
Conlon, Thomas, Christine B. Falkensammer, Rachel Hammond, et al.. (2015). Association of Left Ventricular Systolic Function and Vasopressor Support With Survival Following Pediatric Out-of-Hospital Cardiac Arrest*. Pediatric Critical Care Medicine. 16(2). 146–154. 36 indexed citations
4.
Kirschen, Matthew P., Alexis Topjian, Rachel Hammond, Judy Illes, & Nicholas S. Abend. (2014). Neuroprognostication After Pediatric Cardiac Arrest. Pediatric Neurology. 51(5). 663–668.e2. 18 indexed citations
5.
Cintolo, Jessica A., Phyllis A. Gimotty, DuPont Guerry, et al.. (2013). Local Immune Response Predicts Survival in Patients with Thick (T4) Melanomas. Annals of Surgical Oncology. 20(11). 3610–3617. 20 indexed citations
6.
Valdés, Santiago O., Aaron Donoghue, Rachel Hammond, et al.. (2013). Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. Resuscitation. 85(3). 381–386. 49 indexed citations
7.
Hagemann, Andrea R., Mark G. Cadungog, Ian S. Hagemann, et al.. (2011). Tissue-based immune monitoring I. Cancer Biology & Therapy. 12(4). 357–366. 11 indexed citations
8.
Basu, Devraj, Kathleen T. Montone, Liping Wang, et al.. (2011). Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas. Cell Cycle. 10(12). 2008–2016. 36 indexed citations
9.
Hagemann, Andrea R., Ian S. Hagemann, Mark G. Cadungog, et al.. (2011). Tissue-based immune monitoring II. Cancer Biology & Therapy. 12(4). 367–377. 18 indexed citations
10.
Sasaroli, Dimitra, Phyllis A. Gimotty, Harsh B. Pathak, et al.. (2011). Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biology & Therapy. 12(3). 169–180. 32 indexed citations
11.
Michaylira, Carmen Z., Gabrielle S. Wong, Charles G. Miller, et al.. (2010). Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the Tumor Microenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer. Cancer Research. 70(13). 5281–5292. 97 indexed citations
12.
Facciabene, Andrea, Carmine Carpenito, Fabián Benencia, et al.. (2009). Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. Journal of Translational Medicine. 7(1). 104–104. 35 indexed citations
13.
Yu, Hong, J. Jack Lee, Patrícia A. Possik, et al.. (2009). The Role of BRAF Mutation and p53 Inactivation during Transformation of a Subpopulation of Primary Human Melanocytes. American Journal Of Pathology. 174(6). 2367–2377. 61 indexed citations
14.
Adams, Sarah F., Douglas A. Levine, Mark G. Cadungog, et al.. (2009). Intraepithelial T cells and tumor proliferation. Cancer. 115(13). 2891–2902. 101 indexed citations
15.
Hammond, Rachel, Sandra Blaess, & Asa Abeliovich. (2009). Sonic Hedgehog Is a Chemoattractant for Midbrain Dopaminergic Axons. PLoS ONE. 4(9). e7007–e7007. 37 indexed citations
16.
Gimotty, Phyllis A., et al.. (2009). Therapeutic Effect of Sentinel Lymph Node Biopsy in Melanoma Remains an Open Question. Journal of Clinical Oncology. 27(26). 4236–4238. 14 indexed citations
17.
Xu, Xiaowei, Phyllis A. Gimotty, DuPont Guerry, et al.. (2008). Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis. Human Pathology. 39(6). 901–909. 47 indexed citations
18.
Abeliovich, Asa & Rachel Hammond. (2007). Midbrain dopamine neuron differentiation: Factors and fates. Developmental Biology. 304(2). 447–454. 98 indexed citations
19.
Hammond, Rachel, Arifa Naeem, John K. Chilton, et al.. (2005). Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. Development. 132(20). 4483–4495. 64 indexed citations
20.
Zhong, Ping, Zhensheng Cao, Rachel Hammond, et al.. (1999). Induction of Ribosome Methylation in MLS-Resistant Streptococcus pneumoniae by Macrolides and Ketolides. Microbial Drug Resistance. 5(3). 183–188. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026